Article
Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant.
Protein engineering, design & selection : PEDS - 1 May 2010
Atwell Shane, Brouillette Christie G, Conners Kris, Emtage Spencer, Gheyi Tarun, Guggino William B, Hendle Jorg, Hunt John F, Lewis Hal A, Lu Frances, Protasevich Irina I, Rodgers Logan A, Romero Rich, Wasserman Stephen R, Weber Patricia C, Wetmore Diana, Zhang Feiyu F, Zhao Xun
Abstract excerpt
Upon removal of the regulatory insert (RI), the first nucleotide binding domain (NBD1) of human cystic fibrosis transmembrane conductance regulator (CFTR) can be heterologously expressed and purified in a form that remains stable without solubilizing mutations, stabilizing agents or the regulatory extension (RE). This protein, NBD1 387-646(Delta405-436), crystallizes as a homodimer with a head-to-tail association...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
